Location: | London |
---|---|
Salary: | £39,375 to £41,843 per annum (depending on experience, plus inner London weighting) |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 12th April 2024 |
---|---|
Closes: | 12th May 2024 |
Hours: Full time on site – 36 hours per week
Contract type: Fixed Term - 23 months
Nucleic Acid Therapy Accelerator
The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), has invested a total of £30M over 5 years to establish the Nucleic Acid Therapy Accelerator (NATA) that will support state-of-the-art interdisciplinary research to solve critical issues in nucleic acid therapeutics. NATA has state of the art chemistry and biology laboratories and capabilities located on the Harwell Research and Innovation Campus, Oxfordshire alongside the MRC Harwell Mary Lyon Centre, National Mouse Genetics Facility.
The Role
We are seeking to appoint a highly motivated and enthusiastic postgraduate scientist to work on a collaborative project between NATA and University College London (UCL). The project aims to develop personalized antisense oligonucleotide (ASO) therapy for beta-propeller protein-associated neurodegeneration (BPAN), a rare early onset disorder affecting neuronal function.
Responsibilities
Essential selection criteria
Type / Role:
Subject Area(s):
Location(s):